The Martin Shkreli saga ends today, but the issue he raised on drug pricing seems immortal
Martin Shkreli is offering us one last lesson today on the consequences of criminally bad behavior.
A federal judge, already riled enough by Shkreli’s decision to offer a bounty on Hillary Clinton’s hair to leave him locked up in a Brooklyn prison for 6 months to await sentencing and then force him to forfeit $7.4 million, will sentence him later today on three felony convictions.
In the end, Shkreli tried to strike an apologetic tone for his transgressions. He had lied repeatedly to his investors, manipulated Retrophin stock and feared jail. But prosecutors only threw back a damning series of remarks he had made mocking his enemies, and proudly declaring that he was about to get off nearly scot free, happy to do some short time in Club Fed. They also ridiculed his pretensions about drug development, highlighting an unsupervised drug trial in Cyprus.
This article is for premium subscribers only
Upgrade to a premium subscription plan for unlimited access, and join our community of key biopharma players.